Great Point Partners is a fund manager in Greenwich with $1.49 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
SEC advisor number
801-73834
FINRA CRD number
158423
AUM ?
$1.92 bn
(as of 31 Mar 23)
Accounts
19
(as of 31 Mar 23)
Employees
27
(21 investment advisory or research)
Address
Great Point Partners
165 MASON STREET, 3RD FLOOR
GREENWICH
CT 06830
165 MASON STREET, 3RD FLOOR
GREENWICH
CT 06830
Phone
203 971-3300
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Great Point Partners, LLC | $1.49 bn | |
Biomedical Offshore Value Fund, LTD. | $249.35 mm | Hedge Fund |
Biomedical Value Fund, L.P. | $387.11 mm | Hedge Fund |
GPP II - MDRS Holdings, LLC | $573.04 k | Private Equity Fund |
GPP II - Salmon Co-invest, L.P. | $7.27 mm | Private Equity Fund |
Great Point Partners Ii-a Salmon Aiv, L.P. | ||
Great Point Partners II Salmon Aiv, L.P. | ||
GPP II - Steripack, LLC | $32.23 mm | Private Equity Fund |
GPP II - Ucs, LLC | $17.76 mm | Private Equity Fund |
GPP III - Axiom, LLC | $13.51 mm | Private Equity Fund |
GPP III - Bionova, LLC | $20.31 mm | Private Equity Fund |
GPP III - MLM, LLC | $4.92 mm | Private Equity Fund |
GPP III - PCM, LLC | $32.57 mm | Private Equity Fund |
GPP III - Tergus, LLC | $327.84 k | Private Equity Fund |
Great Point Partners I, L.P. | $27.73 mm | Private Equity Fund |
Great Point Partners Ii-a, LP | $56.56 mm | Private Equity Fund |
Great Point Partners II, LP | $184.52 mm | Private Equity Fund |
GPP II Offshore Feeder, L.P. | Private Equity Fund | |
Great Point Partners Iii-a, L.P. | $68.22 mm | Private Equity Fund |
Great Point Partners III, LP | $386.52 mm | Private Equity Fund |
Great Point Partners IV, L.P. | $506.98 mm | Private Equity Fund |
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G/A
Zura Bio Ltd
14 Feb 24
SC 13G/A
Vistagen Therapeutics, Inc.
14 Feb 24
SC 13G/A
UroGen Pharma Ltd.
14 Feb 24
SC 13G/A
OptiNose, Inc.
14 Feb 24
SC 13G/A
Neurogene Inc.
14 Feb 24
SC 13G/A
HERON THERAPEUTICS, INC. /DE/
14 Feb 24
SC 13G/A
PRECISION BIOSCIENCES INC
14 Feb 24
SC 13G/A
Avalo Therapeutics, Inc.
14 Feb 24
SC 13G/A
ALPINE IMMUNE SCIENCES, INC.
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24